Suppr超能文献

一种具有生物活性的多糖,来源于 ,具有缓解心肌缺血损伤、抗氧化和抗炎作用。

A functional polysaccharide from relieves myocardial ischemia injury anti-oxidative and anti-inflammatory effects.

机构信息

College of Chemical and Pharmaceutical Sciences & Central Laboratory, Qingdao Agricultural University, Qingdao 266109, P. R. China.

Key Laboratory of Coarse Cereal Processing (Ministry of Agriculture and Rural Affairs), Sichuan Engineering & Technology Research Center of Coarse Cereal Industrialization, School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.

出版信息

Food Funct. 2022 Jan 4;13(1):113-120. doi: 10.1039/d1fo03208a.

Abstract

We herein report a food-derived polysaccharide (EJP) with the effect of relieving myocardial ischemia reperfusion injury (MIRI). This novel polysaccharide was isolated from the leaf of , and we first found its myocardium protective effects . Then, we firstly characterized EJP with a series of analytical technologies and further tested its effect on myocardial ischemia reperfusion injury (MIRI) with the illustration of the potential mechanisms . Interestingly, in the murine model of MIRI, administration of EJP effectively improved post-I/R heart contraction and limited the infarct size. Moreover, EJP significantly attenuated IR-induced oxidative damage and inflammatory reaction, as evidenced by decreasing MDA, IL-6, and TNF-α contents and increasing SOD activity and GSH-Px expression. In addition, we proved that EJP not only had no nephrotoxicity but also demonstrated a protective effect on the kidneys through HE staining and biochemical analysis. In sum, EJP, with a significant protective effect against myocardial I/R injury by showing anti-inflammatory and anti-oxidative activities, may become a meaningful drug candidate for the treatment of myocardial I/R injury.

摘要

我们在此报告了一种具有缓解心肌缺血再灌注损伤(MIRI)作用的食源性多糖(EJP)。这种新型多糖从 的叶子中分离出来,我们首次发现了它的心肌保护作用。然后,我们首先用一系列分析技术对 EJP 进行了表征,并进一步通过阐明潜在机制来测试其对心肌缺血再灌注损伤(MIRI)的作用。有趣的是,在 MIRI 的小鼠模型中,EJP 的给药有效改善了再灌注后的心脏收缩并限制了梗死面积。此外,EJP 显著减弱了 IR 诱导的氧化损伤和炎症反应,这表现在 MDA、IL-6 和 TNF-α含量的降低以及 SOD 活性和 GSH-Px 表达的增加。此外,我们证明了 EJP 不仅没有肾毒性,而且通过 HE 染色和生化分析对肾脏表现出保护作用。总之,EJP 通过显示抗炎和抗氧化活性对心肌 I/R 损伤具有显著的保护作用,可能成为治疗心肌 I/R 损伤的有意义的药物候选物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验